This excerpt taken from the ABII 8-K filed Jun 16, 2008.
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our confidence relating to the appeal of the judgment. Because forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including our ability to successfully appeal the judgment. Additional relevant information concerning risks can be found in Abraxis BioSciences Form 10-K for the year ended December 31, 2007 and other documents it has filed with the Securities and Exchange Commission.